Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 13, 2024

SELL
$0.39 - $1.69 $50 - $219
-130 Closed
0 $0
Q1 2023

Aug 13, 2024

BUY
$1.75 - $3.14 $227 - $408
130 New
130 $228,000
Q2 2021

Aug 13, 2024

SELL
$22.12 - $32.06 $11,944 - $17,312
-540 Closed
0 $0
Q4 2020

Aug 13, 2024

BUY
$14.05 - $29.0 $7,587 - $15,660
540 New
540 $13.3 Million
Q2 2020

Aug 13, 2024

BUY
$13.25 - $21.72 $5,631 - $9,231
425 Added 274.19%
580 $9.37 Million
Q1 2020

Aug 13, 2024

BUY
$9.73 - $24.9 $729 - $1,867
75 Added 93.75%
155 $2.23 Million
Q1 2019

Aug 13, 2024

BUY
$28.11 - $50.77 $2,248 - $4,061
80 New
80 $3.46 Million
Q4 2018

Aug 13, 2024

BUY
$26.22 - $56.89 $2,097 - $4,551
80 New
80 $2.15 Million

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $975M
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.